1. Home
  2. EVCM vs AMPH Comparison

EVCM vs AMPH Comparison

Compare EVCM & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVCM
  • AMPH
  • Stock Information
  • Founded
  • EVCM 2006
  • AMPH 1996
  • Country
  • EVCM United States
  • AMPH United States
  • Employees
  • EVCM N/A
  • AMPH N/A
  • Industry
  • EVCM EDP Services
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVCM Technology
  • AMPH Health Care
  • Exchange
  • EVCM Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • EVCM 2.0B
  • AMPH 2.5B
  • IPO Year
  • EVCM 2021
  • AMPH 2014
  • Fundamental
  • Price
  • EVCM $10.75
  • AMPH $51.45
  • Analyst Decision
  • EVCM Buy
  • AMPH Buy
  • Analyst Count
  • EVCM 11
  • AMPH 4
  • Target Price
  • EVCM $11.45
  • AMPH $63.00
  • AVG Volume (30 Days)
  • EVCM 68.3K
  • AMPH 268.7K
  • Earning Date
  • EVCM 11-12-2024
  • AMPH 11-06-2024
  • Dividend Yield
  • EVCM N/A
  • AMPH N/A
  • EPS Growth
  • EVCM N/A
  • AMPH 62.07
  • EPS
  • EVCM N/A
  • AMPH 3.15
  • Revenue
  • EVCM $691,687,000.00
  • AMPH $712,891,000.00
  • Revenue This Year
  • EVCM $4.47
  • AMPH $18.04
  • Revenue Next Year
  • EVCM $5.08
  • AMPH $4.41
  • P/E Ratio
  • EVCM N/A
  • AMPH $16.26
  • Revenue Growth
  • EVCM 6.23
  • AMPH 31.80
  • 52 Week Low
  • EVCM $6.22
  • AMPH $36.56
  • 52 Week High
  • EVCM $12.35
  • AMPH $65.92
  • Technical
  • Relative Strength Index (RSI)
  • EVCM 60.86
  • AMPH 59.40
  • Support Level
  • EVCM $10.42
  • AMPH $49.38
  • Resistance Level
  • EVCM $10.90
  • AMPH $51.84
  • Average True Range (ATR)
  • EVCM 0.19
  • AMPH 1.25
  • MACD
  • EVCM 0.04
  • AMPH 0.10
  • Stochastic Oscillator
  • EVCM 88.61
  • AMPH 78.90

About EVCM EverCommerce Inc.

EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is primarily generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts..

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: